Lv56
1418 积分 2025-07-17 加入
Recognition of necroptosis: From molecular mechanisms to detection methods
1个月前
已完结
Factors Contributing to the Progression of Osteoarthritis after Rotational Acetabular Osteotomy: A Study of 183 Hips with a Median Follow-Up Period of 14 Years
2个月前
已完结
Long-term course of developmental dysplasia of the hip: follow-up of the non-operated hips of patients undergoing unilateral rotational acetabular osteotomy for twenty-four years
2个月前
已完结
A 30-year follow-up study of rotational acetabular osteotomy for pre- and early-stage osteoarthritis secondary to dysplasia of the hip
2个月前
已关闭
CRISPR technology: A decade of genome editing is only the beginning
2个月前
已完结
Long-term results of Bernese periacetabular osteotomy using a dual approach in hip dysplasia
2个月前
已完结
A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice
2个月前
已完结
Parvalbumin as a Pleomorphic Protein
2个月前
已关闭
Ultrasound‐Activated Probiotics Vesicles Coating for Titanium Implant Infections Through Bacterial Cuproptosis‐Like Death and Immunoregulation
2个月前
已完结
A polypeptide coating for preventing biofilm on implants by inhibiting antibiotic resistance genes
2个月前
已完结
[Two Chinese cases with STAT1 gene gain-of-function variation]
1个月前
已采纳
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已采纳
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已采纳
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已驳回
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已驳回
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已采纳
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已采纳
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已采纳
皖公网安备34019202002308
